Joint replacement is one of the commonest elective procedure performed in the elderly veterans. Database studies assume the occurrence of revision to be the same side as the most recent primary, in the absence of laterality being captures in claims databases. A recent Medicare study found that such an assumption had a significant error rate with only 71% revision on the same side as the most recent joint replacement. METHODS: We utilized the Veterans Affairs (VA) administrative and clinical databases from fiscal years 2002 to 2010. We defined the joint replacement cohort based on the presence of Common Procedure Terminology (CPT) codes for total knee, hip or shoulder joint arthroplasty (TKA, THA, TSA). We used NLP ascertainment of laterality of primary and revision joint replacement. RESULTS: The cohorts consisted of 84,495 patients with 87,495 procedures. Mean age was 63 years, 94% were male; 84% were Caucasian, 14% were African-American and 2% were other. 73,488 had operative notes available and constituted our analytic dataset. Joint laterality was established based on text data for >98% of primary and >97% of all joint replacement cohorts. We found that 57% of the primary TKA were right, 41% were left and 1% simultaneous bilateral. Similar proportions were noted for primary THA and primary TSA. For revision TKA, THA and TSA, similar proportions were noted. CONCLUSIONS: NLP can obtain the laterality of joint replacement surgery and this can assist in improving the quality of database studies of joint replacement surgery that use the VA databases. 
PRM59 ESTABLISHING A WEIGHTING METHODOLOGY TO COMPUTE THE NUMBER OF PATIENTS WITH DISEASE USING CLAIMS DATA AND CENSUS POPULATION IN THE UNITED STATES

OBJECTIVES:
Commercial claims databases are thought to over-represent working age groups and under-represent older age groups because of employment bias attributable to their population of working age individuals, and their dependents, who have employer based insurance coverage. METHODS: Four disease classifications (acute coronary syndromes, dyslipidemia, breast cancer, and major depressive disorder [MDD] ), and four drugs classes (statins, anti-platelets, anti-estrogens and atypical antipsychotics) were used to develop and evaluate linear weighting methods compared to the United States (US) Census data. Any patient within the HealthCore Integrated Research Database (HIRD) with a claim for any of the disease or drug classifications during 2009 was eligible for this analysis. This year was selected because it was the latest year for which US Census data were available. Linear weighting method was used as the 'Weight = Estimated Population Value from the US Census/HIRD value. RESULTS: A total of 14,794,609 patients in the HIRD met the inclusion criteria. Weights were calculated for the Mid-West, West, North-East and South geographic regions, and were stratified by gender and age using US Census age groups. For example, for 1,227 North-East-based male patients, aged 15-19 years, in the HIRD database who were diagnosed with an MDD the weight derived from US Census data was 1.10, indicating that an estimated 1,353 patients in the North-East region with MDD. CONCLUSIONS: The number of individuals in the US population with any one of four disease or drug classifications can be safely estimated using a linear weighting methodology, which makes it possible to calculate estimates of the total number of patients in the US population, or by geographic region, and further stratified by age group and gender. Such estimation is useful for research requiring estimation numbers of patients with a disease condition or pharmacy utilization. OBJECTIVES: Substantial evidence suggests that following an enhanced recovery after surgery (ERAS) program is effective in improving post-surgical outcomes. To examine the potential associations between compliance with ERAS protocol elements and post-op fluid use, opioid use, hospital length of stay (LOS), hospital costs, and readmissions, would require combining data elements from the ERAS program with regularly collected retrospective data elements in a large multihospital database. The objective of this study was to combine information from a prospective dataset with a matched retrospective data source. METHODS: Duke University Medical Center (DUMC) collected data on colorectal surgery patients in order to determine eligibility for inclusion in the study. With IRB approval, we matched selected patients in the Premier research database on criteria of age, gender, discharge date, procedure date, length of stay, presence of a colorectal procedure during stay, and presence of a colorectal procedure. All matches were verified by physicians at DUMC. RESULTS: Of the 240 patients in the DUMC database, 206 (85.8%) matched on all variables. One other patient matched, except on having a colorectal procedure on an identical date. Thirteen (5.4%) were a match, except on length of stay. Expanding the age criteria to ±1 year, we were able to match 7 (2.9%) additional patients. Similarly, allowing the procedure date to match within ±1 day increased the total by one more patient. Eight (3.3%) patients required a manual match by discharge date and presence of a colorectal procedure during the hospital stay. The final four (1.7%) patients could not be matched because their discharge date was outside the range of the Premier database. CONCLUSIONS: Using the different matching approaches criterion, we were able to link nearly all patients from the DUMC prospective database to the Premier retrospective dataset. This flexible approach can be utilized with other databases.
PRM60 ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL AND POSTOPERATIVE OUTCOMES: PROSPECTIVELY CAPTURED DATA COMBINED WITH A RETROSPECTIVE DATABASE
PRM61 EVALUATING THE EMILIA-ROMAGNA REGION DATABASE FOR INVESTIGATING TREATMENT OUTCOMES: THE CASE OF ANTIPSYCHOTICS AND MORTALITY
OBJECTIVES:
To evaluate the use of the population-based Emilia-Romagna region (RER) administrative database for drug outcomes studies using as an example the previously documented increased mortality risk amongst new users of conventional versus atypical antipsychotic medications. METHODS: We conducted a new user cohort study among 23,681 Italian RER patients aged 65 or older who initiated treatment with a conventional or atypical antipsychotic between July 1, 2009 and June 30, 2011. The 180-day mortality was compared for patients in each treatment group using Cox proportional hazards models that were adjusted for mortality risk factors, including demographic and clinical characteristics, use of other medications, and measures of health services utilization intensity, all measured prior to antipsychotic initiation. We conducted a systematic review and meta-analysis of studies with similar methods against which we compared our results. RESULTS: Amongst 14,462 patients prescribed conventional and 9,212 prescribed atypical antipsychotics, we observed 2,402 (16.6%) and 821(8.9%) deaths during follow-up, respectively. New users of conventional antipsychotics were older and generally had higher prevalences of outcome risk factors and higher health service use intensity at baseline. The crude hazard ratio (HR) was 1.95 (95% confidence interval [CI], 1.80-2.11), which decreased to 1.47 (95% CI, 1.35-1.60) after full adjustment. We identified seven published studies examining this association using similar methods. The pooled HR from these seven studies was 1.34 (95% CI, 1.28-1.39). Upon inclusion of our study, the meta-analysis yielded a summary estimate of 1.35 (95% CI, 1.31-1.40) without introducing any heterogeneity (I 2 = 0%; p=0.455). CONCLUSIONS: Our results support the findings of previous studies and provide a refined estimate of the association between increased mortality amongst elderly patients taking conventional versus atypical antipsychotics. Our study provides support for the use of the RER database for pharmacoepidemiology studies. 
PRM62 UTILIZING PHARMACY RETAIL DATA TO MEASURE PRIMARY MEDICATION NON-ADHERENCE
OBJECTIVES:
The purpose of the study was to calculate primary medication nonadherence (PMN), using the Pharmacy Quality Alliance's (PQA) quality measure with retail pharmacy transaction data. Primary non-adherence is an instance whereby patients fail to initiate a pharmacotherapy regimen following a recommendation by a physician or other health care provider (a prescription). METHODS: De-identified, pharmacy transactional data for calendar years 2010 and 2011 from 100 pharmacies of a pharmacy grocery chain were used. Primary medication non-adherence was defined as when a new medication was prescribed for a patient age 18 or older, but was not obtained from the pharmacy within 30 days. A set list of chronic medications was constructed that would warrant a patient needing to pick the medication up in a timely manner to begin therapy. Additionally, only electronic prescriptions were assessed as the data captured for prescription origination date and medication pickup date could not be genuinely accounted for in paper prescriptions. A prescription was categorized as new drug therapy if the medicine prescribed (or its generic equivalent) had not been filled for the patient by the pharmacy during the prior 180 days. If the prescription was deemed to be a newly initiated drug therapy, it was included in the denominator for the measure. The numerator was populated when a newly initiated drug therapy or its therapeutic equivalent was not filled
